Member News

-
Valeo Pharma Reports Its First Quarter 2022 Results and Highlights
Q1-22 revenues of $4.2 million, up 128% over Q1-21 Q1-22 gross margins of $1.4 million, up 266% over Q1-21 Public…
-
Zentek’s ZenGUARD(TM) Patent Application Publishes
March 24, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization…
-
Sixth Wave Announces Closing of $2.568M Financing
March 24, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or the “Company”) is…
-
Nano One Provides Update on Emerging LFP Opportunity
2035 global LFP market projected to grow 13X, exceed 1 TWh and reach tens of billions of dollars. [1]…
-
Hemostemix Announces Settlement Agreement
March 23, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…